NEXTCURE, INC Operating Cash Flow
NEXTCURE, INC (NXTC) reported Operating Cash Flow of -$23.08 million for the 6-month period ending 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-18
- NEXTCURE, INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.71M.
- NEXTCURE, INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$13.36M.
- NEXTCURE, INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$7.64M.
- NEXTCURE, INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.27M.
- NEXTCURE, INC net cash provided by (used in) operating activities for fiscal 2023 was -$52.97M.
- NEXTCURE, INC net cash provided by (used in) operating activities for fiscal 2022 was -$53.89M.
- NEXTCURE, INC net cash provided by (used in) operating activities for fiscal 2021 was -$57.28M.
- NEXTCURE, INC net cash provided by (used in) operating activities for fiscal 2020 was -$44.95M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$9.71M derived: S-4 6 month − 10-Q 3 month · filed 2026-08-18 | -$23.08M S-4 · filed 2026-08-18 | -$30.72M derived: sum of 3 quarters · filed 2026-08-18 | -$36.98M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2026-03-31 | -$13.36M 10-Q · filed 2026-05-07 | -$21.00M derived: sum of 2 quarters · filed 2026-08-18 | -$27.27M derived: sum of 3 quarters · filed 2026-08-18 | -$49.98M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-12-31 | -$7.64M derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18 | -$13.91M derived: sum of 2 quarters · filed 2026-08-18 | -$36.62M derived: sum of 3 quarters · filed 2026-08-18 | -$49.61M S-4 · filed 2026-08-18 | |
| 2025-09-30 | -$6.27M derived: 10-Q 9 month − S-4 6 month · filed 2025-11-05 | -$28.98M derived: sum of 2 quarters · filed 2026-08-18 | -$41.98M 10-Q · filed 2025-11-05 | -$48.94M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-06-30 | -$22.71M derived: S-4 6 month − 10-Q 3 month · filed 2026-08-18 | -$35.71M S-4 · filed 2026-08-18 | -$42.68M derived: sum of 3 quarters · filed 2026-08-18 | -$54.13M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-03-31 | -$12.99M 10-Q · filed 2026-05-07 | -$19.96M derived: sum of 2 quarters · filed 2026-08-18 | -$31.42M derived: sum of 3 quarters · filed 2026-08-18 | -$41.19M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2024-12-31 | -$6.97M derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18 | -$18.42M derived: sum of 2 quarters · filed 2026-08-18 | -$28.20M derived: sum of 3 quarters · filed 2026-08-18 | -$40.80M S-4 · filed 2026-08-18 | |
| 2024-09-30 | -$11.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$21.23M derived: sum of 2 quarters · filed 2025-11-05 | -$33.84M 10-Q · filed 2025-11-05 | -$44.51M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | -$9.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$22.38M 10-Q · filed 2025-08-07 | -$33.05M derived: sum of 3 quarters · filed 2025-08-07 | -$45.83M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | -$12.61M 10-Q · filed 2025-05-01 | -$23.28M derived: sum of 2 quarters · filed 2025-05-01 | -$36.05M derived: sum of 3 quarters · filed 2025-05-01 | -$50.80M derived: sum of 4 quarters · filed 2025-05-01 | |
| 2023-12-31 | -$10.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$23.45M derived: sum of 2 quarters · filed 2025-03-06 | -$38.20M derived: sum of 3 quarters · filed 2025-03-06 | -$52.97M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$12.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$27.52M derived: sum of 2 quarters · filed 2024-11-07 | -$42.30M 10-Q · filed 2024-11-07 | -$51.25M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$14.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$29.53M 10-Q · filed 2024-08-01 | -$38.48M derived: sum of 3 quarters · filed 2024-08-01 | -$53.48M derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | -$14.78M 10-Q · filed 2024-05-02 | -$23.73M derived: sum of 2 quarters · filed 2024-05-02 | -$38.73M derived: sum of 3 quarters · filed 2024-05-02 | -$53.22M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | -$8.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$23.95M derived: sum of 2 quarters · filed 2024-03-21 | -$38.44M derived: sum of 3 quarters · filed 2024-03-21 | -$53.89M 10-K · filed 2024-03-21 | |
| 2022-09-30 | -$15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$29.49M derived: sum of 2 quarters · filed 2023-11-02 | -$44.94M 10-Q · filed 2023-11-02 | -$58.42M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$14.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$29.94M 10-Q · filed 2023-08-03 | -$43.42M derived: sum of 3 quarters · filed 2023-08-03 | -$56.09M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$15.45M 10-Q · filed 2023-05-04 | -$28.93M derived: sum of 2 quarters · filed 2023-05-04 | -$41.60M derived: sum of 3 quarters · filed 2023-05-04 | -$58.82M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | -$13.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$26.15M derived: sum of 2 quarters · filed 2023-03-02 | -$43.37M derived: sum of 3 quarters · filed 2023-03-02 | -$57.28M 10-K · filed 2023-03-02 | -$57.24M 10-K · filed 2022-03-03 |
| 2021-09-30 | -$12.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$29.88M derived: sum of 2 quarters · filed 2022-11-03 | -$43.80M 10-Q · filed 2022-11-03 | -$50.07M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | -$17.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$31.13M 10-Q · filed 2022-08-04 | -$37.41M derived: sum of 3 quarters · filed 2022-08-04 | -$53.08M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | -$13.91M 10-Q · filed 2022-05-05 | -$20.19M derived: sum of 2 quarters · filed 2022-05-05 | -$35.86M derived: sum of 3 quarters · filed 2022-05-05 | -$48.27M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$21.95M derived: sum of 2 quarters · filed 2022-03-03 | -$34.36M derived: sum of 3 quarters · filed 2022-03-03 | -$44.95M 10-K · filed 2022-03-03 | |
| 2020-09-30 | -$15.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$28.08M derived: sum of 2 quarters · filed 2021-11-04 | -$38.68M 10-Q · filed 2021-11-04 | -$48.67M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$12.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$23.00M 10-Q · filed 2021-08-05 | -$32.99M derived: sum of 3 quarters · filed 2021-08-05 | -$40.94M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$10.59M 10-Q · filed 2021-05-06 | -$20.59M derived: sum of 2 quarters · filed 2021-05-06 | -$28.53M derived: sum of 3 quarters · filed 2021-05-06 | -$39.14M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$9.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$17.94M derived: sum of 2 quarters · filed 2021-03-04 | -$28.54M derived: sum of 3 quarters · filed 2021-03-04 | -$35.62M 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$7.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$18.55M derived: sum of 2 quarters · filed 2020-11-05 | -$25.63M 10-Q · filed 2020-11-05 | -$3.16M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | -$10.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$17.68M 10-Q · filed 2020-08-06 | $4.79M derived: sum of 3 quarters · filed 2020-08-06 | $67.00K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | -$7.08M 10-Q · filed 2020-05-07 | $15.39M derived: sum of 2 quarters · filed 2020-05-07 | $10.67M derived: sum of 3 quarters · filed 2020-05-07 | $5.71M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $22.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $17.75M derived: sum of 2 quarters · filed 2020-03-12 | $12.79M derived: sum of 3 quarters · filed 2020-03-12 | $7.99M 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$4.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$9.68M derived: sum of 2 quarters · filed 2019-11-12 | -$14.48M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$9.76M 10-Q · filed 2019-08-12 | |||
| 2018-03-31 | -$4.80M 10-Q · filed 2019-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |